Research Correspondence

DOI: 10.4244/EIJ-D-25-00025

Validation of the pullback pressure gradient in resting conditions

Koshiro Sakai1,2,3, MD, PhD; Jeroen Sonck1, MD, PhD; Takuya Mizukami1,4,5, MD, PhD; Hitoshi Matsuo5, MD, PhD; Brian Ko6, MD, PhD; Divaka Perera7, MD, FRCP; Hirohiko Ando8, MD, PhD; Simone Biscaglia9, MD, PhD; Fernando Rivero10, MD, PhD; Antonio Maria Leone11,12, MD, PhD; Liyew Desta13, MD, PhD; Javier Escaned14, MD, PhD; Masafumi Nakayama15, MD, PhD; Daniel Munhoz1, MD, PhD; Tatyana Storozhenko1,16, MD; Hirofumi Ohashi8, MD, PhD; Gianluca Campo9, MD, PhD; Tetsuya Amano8, MD, PhD; Toshiro Shinke2, MD, PhD; Ziad Ali3, MD, DPhil; Bernard De Bruyne1,17, MD, PhD; Nils P. Johnson18, MD, MS; Carlos Collet1, MD, PhD; Allen Jeremias3, MD, MSc

The pullback pressure gradient (PPG) is a novel metric that quantifies coronary artery disease (CAD) patterns as focal or diffuse on a scale from 0 (diffuse) to 1 (focal)1. PPG predicts blood flow improvement after percutaneous coronary intervention (PCI): a high PPG (focal disease) is associated with greater flow improvement and angina relief, while a low PPG (diffuse disease) is linked to higher periprocedural complications23. Traditionally, PPG has been derived from fractional flow reserve (FFR) pullbacks. However, assessment using non-hyperaemic pressure ratios (NHPR) can shorten procedure time and eliminate the need for a hyperaemic agent. This study aimed to assess the agreement between resting and hyperaemic PPG.

This study was a prespecified subanalysis of the PPG Global Registry, a prospective, investigator-initiated, multicentre, international study (ClinicalTrials.gov: NCT04789317)2. Eligible patients had at least one haemodynamically significant lesion (FFR ≤0.80) scheduled for PCI, with those undergoing both resting and hyperaemic pressure pullbacks included (Supplementary Figure 1). The pressure wire (PressureWire X [Abbott]) was placed in the distal coronary artery to measure resting distal coronary pressure/aortic pressure, resting full-cycle...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 14
Jul 21, 2025
Volume 21 Number 14
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00055 Dec 18, 2023
Pullback pressure gradient index: can it predict plaque phenotype?
Bourantas C and Yap N
free

Clinical research

10.4244/EIJ-D-23-00516 Dec 18, 2023
Preprocedural physiological assessment of coronary disease patterns to predict haemodynamic outcomes post-PCI
Kotoku N et al
free

State-of-the-Art Review

10.4244/EIJ-D-20-00988 Apr 2, 2021
Optimising physiological endpoints of percutaneous coronary intervention
Al-Lamee R et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-18-00064 Jul 20, 2018
Pressure wire compared to microcatheter sensing for coronary fractional flow reserve: the PERFORM study
Ali ZA et al
free

10.4244/EIJV17I4A47 Jul 20, 2021
Coronary flow capacity: where to next?
Johnson NP and Gould K
free

EXPERT REVIEW

10.4244/EIJ-D-17-00503 Aug 25, 2017
State of the art: pressure wire and coronary functional assessment
Echavarria-Pinto M et al
free
Trending articles
225.25

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
80.05

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
47

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved